Corengi Launches New Web Site to Help Type 2 Diabetes Patients Find Suitable Clinical Trials
www.corengi.com simplifies the clinical trial selection process; enables type 2 diabetes patients to learn which trials are right for them.
Seattle, WA, October 28, 2010 --(PR.com)-- Corengi, Inc. today announced it has launched a new web site – www.corengi.com – to help type 2 diabetes patients find clinical trials. The free online tool asks patients a few simple questions about their condition, including weight, blood sugar, and medications, to help them identify which ongoing clinical trials may be appropriate for them. According to the Center for Disease Control and Prevention, 23.6 million Americans (or 7.8 percent of the population) have diabetes, of which between 90 and 95 percent have type 2. Currently, the main online sources of type 2 diabetes clinical trial information are either incomplete, confusing, or both. With its comprehensive listing of all ongoing type 2 diabetes clinical trials in the U.S. (almost 400, 115 of which were launched since early 2010), Corengi simplifies the process of clinical trial selection for patients, and helps them quickly understand which clinical trials might be suitable.
A patient will only qualify to participate in a small percentage of these trials. Corengi gathers answers to a set of key questions needed to identify which clinical trials are appropriate for each patient and matches patients with the right clinical trial options.
“We recently surveyed 145 diabetes patients who had previously participated in a clinical trial,” explains Ryan Luce, co-founder of Corengi. “The vast majority of respondents (88 percent) indicated that they would recommend other diabetes patients to look into clinical trials. Corengi hopes to provide a simple way for type 2 diabetes patients to explore that option further.”
The American Diabetes Association endorses the multiple benefits of clinical trials: “A trial might be the only way to obtain a new cutting-edge drug or procedure, and patients on trials often receive free expert advice about taking care of their diabetes. Finally, there is the satisfaction of knowing that because of your efforts, we will better understand diabetes, and you will have contributed in a real way to making diabetes a thing of the past.” (source: http://www.diabetes.org/news-research/research/clinical-trials/participation-in-clinical-research.html)
About Corengi, Inc.
Headquartered in Seattle, WA, Corengi was founded in 2010 by healthcare industry veteran Ryan Luce and seasoned web entrepreneur Elliot Cohen. Corengi is dedicated to helping individuals discover more about clinical trials that may be appropriate for them, and committed to building a free, comprehensive, and interactive platform for a variety of diseases. This online platform will allow stakeholders within the clinical trials community, including investigators, site personnel, sponsors, and disease advocates, to engage with potential enrollees and educate them about specific clinical trials. For more information, visit us online at www.corengi.com.
###
A patient will only qualify to participate in a small percentage of these trials. Corengi gathers answers to a set of key questions needed to identify which clinical trials are appropriate for each patient and matches patients with the right clinical trial options.
“We recently surveyed 145 diabetes patients who had previously participated in a clinical trial,” explains Ryan Luce, co-founder of Corengi. “The vast majority of respondents (88 percent) indicated that they would recommend other diabetes patients to look into clinical trials. Corengi hopes to provide a simple way for type 2 diabetes patients to explore that option further.”
The American Diabetes Association endorses the multiple benefits of clinical trials: “A trial might be the only way to obtain a new cutting-edge drug or procedure, and patients on trials often receive free expert advice about taking care of their diabetes. Finally, there is the satisfaction of knowing that because of your efforts, we will better understand diabetes, and you will have contributed in a real way to making diabetes a thing of the past.” (source: http://www.diabetes.org/news-research/research/clinical-trials/participation-in-clinical-research.html)
About Corengi, Inc.
Headquartered in Seattle, WA, Corengi was founded in 2010 by healthcare industry veteran Ryan Luce and seasoned web entrepreneur Elliot Cohen. Corengi is dedicated to helping individuals discover more about clinical trials that may be appropriate for them, and committed to building a free, comprehensive, and interactive platform for a variety of diseases. This online platform will allow stakeholders within the clinical trials community, including investigators, site personnel, sponsors, and disease advocates, to engage with potential enrollees and educate them about specific clinical trials. For more information, visit us online at www.corengi.com.
###
Contact
Corengi, Inc.
Ryan Luce
(713) 364-4639
www.corengi.com
Ryan Luce
(713) 364-4639
www.corengi.com
Contact
Categories